Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. NEOVACS
  6. Summary
    ALNEV   FR0004032746

NEOVACS

(ALNEV)
  Report
Real-time Quote. Real-time Euronext Paris - 09/27 11:35:20 am
0.0027 EUR   -3.57%
11:10aGLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
09/06GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...
09/05Neovacs S.A. announced a financing transaction
CI
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
09/21/2021 09/22/2021 09/23/2021 09/24/2021 09/27/2021 Date
0.0027(c) 0.0026(c) 0.0028(c) 0.0028(c) 0.0027 Last
287 403 470 153 322 122 195 980 903 193 129 987 321 870 893 Volume
0.00% -3.70% +7.69% 0.00% -3.57% Change
More quotes
Estimated financial data (e)
Sales 2019 0,10 M 0,11 M 0,11 M
Net income 2019 -7,55 M -8,83 M -8,83 M
Net cash position 2019 1,23 M 1,44 M 1,44 M
P/E ratio 2019 -1,21x
Yield 2019 -
Sales 2020 0,03 M 0,04 M 0,04 M
Net income 2020 -6,14 M -7,19 M -7,19 M
Net cash position 2020 9,68 M 11,3 M 11,3 M
P/E ratio 2020 -3,31x
Yield 2020 -
Capitalization 16,6 M 19,5 M 19,5 M
EV / Sales 2019 74,3x
EV / Sales 2020 -137x
Nbr of Employees 15
Free-Float 99,6%
More Financials
Company
Neovacs SA is a France-based company active in the biotechnology industry. It specializes in immunotherapy domain and providing treatment for autoimmune and inflammatory diseases. The Company researches and develops Kinoids, drug-candidates which aim to treat disease by including an antibody response in the patient. The Company focuses its development effort on two Kinoids for Crohn’s disease, Rheumatoid Arthritis... 
More about the company
All news about NEOVACS
11:10aGLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
09/06GLOBAL MARKETS LIVE : Puma, Boeing, Holcim, Revolut, Amazon...
09/05Neovacs S.A. announced a financing transaction
CI
09/05Neovacs S.A. announced that it has received €2 million in funding from European High Gr..
CI
08/19Neovacs S.A. announced that it expects to receive €2 million in funding from European H..
CI
07/07GLOBAL MARKETS LIVE : Wise, Amazon, Microsoft, Nintendo, Nikola....
07/05GLOBAL MARKETS LIVE : WM Morrison, IBM, Didi...
06/29Neovacs S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
06/22GLOBAL MARKETS LIVE : Netflix, Boeing, Tesla, Delta Air Lines, Blackstone Resources....
06/21Neovacs S.A. announced that it has received €4 million in funding
CI
06/08Neovacs S.A. announced that it expects to receive €2 million in funding from European H..
CI
05/17GLOBAL MARKETS LIVE : AT&T, GSK, Discovery, Microsoft, Tesla...
2020Neovacs S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
2020NEOVACS : Monthly statement on outstanding equity shares and voting rights
CO
2020NEOVACS : Tableau de suivi des VM donnant accès au capital (OCEANEs) au 11/08/2020
PU
More news
News in other languages on NEOVACS
04:43aNÉOVACS : investissement dans Bio Detection K9
03:09aLes valeurs à suivre aujourd'hui à la Bourse de Paris Lundi 27 septembre 2021
03:01aSTOCK MARKET PARIS : Power Crunch ?
02:36aNÉOVACS : investit 5 millions de dollars dans la détection canine de bactéries et de virus
02:24aEN DIRECT DES MARCHES : Faurecia, Publicis, Plastic Omnium, Bonduelle, Credit Suisse, Zoop..
More news
Chart NEOVACS
Duration : Period :
NEOVACS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Vincent Serra Chief Executive Officer
Baptiste Pourtout Chief Financial Officer
Thérèse Croughs Chief Medical Officer
Patrick Valroff Independent Director
Daniel Zagury Director
Sector and Competitors
1st jan.Capi. (M$)
NEOVACS-90.73%19
MODERNA, INC.311.74%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.46.01%50 128
CELLTRION, INC.-23.54%31 745
SEAGEN INC.-7.88%29 353